ATM Signaling Pathway (Homo sapiens)

From WikiPathways
Jump to: navigation, search
Cell response Activation path Inhibition path Triggered Damage P MDM2 P ATM P Chk2 P PIDD P Chk1 P FANCD2 P c-Abl P IKBA P ATM IR Radiation MDMX Ubiquitination & Degradation STRUCTURAL CHANGE OF CHROMATIN Inactive Dimer Cell Survival MRN Complex P BID Cell Survival Synaptic Vesicle Transport CDC25A P DNA Repair Cyclin B GADD45A CREB1 P p21 TP73 NEMO RIP1 CDC25C P SMC1A Apoptosis AP3B2 Apoptosis G2/M Transition CDK1 H2AX RAD9A P RAD51 P TLK1 CDC2 CCNE1 CDK2 BRCA1 SAPK (MAPK9) Cell Death Senescence MDMX (MDM4) MDM2 S Phase Arrest TP53 P DNA Repair Recombination CDK2 MDC1 RAIDD NF kappa B Pathway G2/M Checkpoint Arrest Caspase 2 S Phase Progression G1/S Checkpoint Arrest ATF2 P DNA Repair c-Jun TP53BP1 S Phase Progression ATM ATM Cell Cycle Checkpoint Activation MRE11 NBS1 RAD50 DNA DAMAGE Cell Survival RAD50 MRE11 NBS1 P P Name: ATM Signaling Pathway Organism: Homo sapiens


Ataxia-telangiectasia (A-T) is a highly pleiotropic, autosomal recessive disease that leads to multisystem defects and has an intricate cellular phenotype, all linked to the functional inactivation of a single gene. Extensive research on the phenotype and the recent discovery and cloning of the responsible gene point to a defect as a central biochemical locus which links several signal transduction pathways that operate under stress as well as in normal physiological conditions.

Ataxia is the first symptom in all patients and is predominantly truncal, first manifested in swaying of the head and trunk on standing and even sitting. Truncal ataxia precedes appendicular cerebellar disease. In the first years of life, certain manifestations are present such as dysarthria, muscular hypotonia, the slow initiation and performance of all voluntary movements, characteristic hypotonic facies and postures, and drooling. Dyssynergia and intention tremor of the upper extremities become a major feature after the fifth year of life. The tendon reflexes are diminished or lost, but may be normal or even hyperactive in the early stages. All these observations show a clear ataxia of cerebellar type, initially of station and gait, and later of intention. Early observations of brains from patients with A-T showed neurodegenerative changes, particularly in the Purkinje and granular cells of the cerebellum. Neuronal degeneration is also present in the brainstem, and dentate and olivary nuclei atrophy. Neuronal loss occurs in the substantial nigra and oculomotor nuclei, dorsal root ganglia, and degenerative changes are evident in spinal motor neurons, and dorsal root and sympathetic motor neurons. Moreover, multiple abnormalities in Purkinje cell development have been observed in an Atm-deficient mouse model. Misplaced Purkinje cells have been observed in both the granular and molecular cell layers. In addition, Purkinje cell dendrites tend to grow laterally instead of extending towards the surface of the cerebellum.

ATM (for Ataxia-telangiectasia mutated) has been located by restriction-fragment length polymorphism in the chromosome 11, location: 108,093,211-108,239,829. Interestingly, the site of ATM is the same or adjacent to the region occupied by CD3 (Antigen, Delta subunit), THY1 (T-Cell antigen), and NCAM (Cell Adhesion Molecule, Neural, 1) genes, all of which are members of the immunoglobulin-gene superfamily and consequently may be subject to the same defect that afflicts the T-cell receptor and immunoglobulin molecules in A-T. The ATM gene presents an open reading frame (ORF) of 9,165 kb cDNA and is constituted by 66 exons spread over 150 kb of genomic DNA which has a transcript of 12 kb. The ORF of this transcript predicts a 370-kDa protein composed of 3056 amino acids. Over 300 mutations have been found in A-T patients, distributed across the full length (150 kb of genomic DNA) of the ATM gene.

Sequence homology indicates that the atm gene product falls into a family of proteins that are related to the catalytic subunit of phosphatidylinositol 3-kinase (PI 3-kinase). This family includes TEL1, MEC1, TOR1, and TOR2 of the budding yeast Saccharomyces cerevisiae, RAD3 of the fission yeast Schizosaccharomyces pombe, and MEI-41 of Drosophila melanogaster. The mammalian family member most closely related to ATM is the ATR/FRP1 protein and, like its yeast homologs, it mediates cellular responses to unreplicated or damaged DNA. In humans the PI 3-kinase family includes the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs) and FRAP. These sequence homologies appear to reflect functional homology because many of the PI 3-kinase family members are involved in DNA repair, recombination and cell cycle control. Despite the resemblance to lipid kinases, members of this family, including ATM, possess a serine/threonine protein kinase activity, which is wortmannin sensitive.

ATM phosphoprotein is ubiquitously expressed and predominantly found in nuclei of proliferating cells, but subcellular fractionation and immunofluorescence revealed that 10-20% of the protein is present in cytoplasmic vesicles, including peroxisomes and endosomes and a prominent cytoplasmic fraction in mouse oocytes. ATM is endosome-bound in mouse neurons, suggesting molecular sorting of the protein occurs in the cytoplasm. In Purkinje cells, distribution of ATM protein is primarily in cytoplasm, and this may be related to the differentiation state of the cells. ATM mRNA is present in all human and mouse tissues. In situ hybridization shows that ATM mRNA is expressed throughout the whole mouse embryo. Furthermore, ATM has been associated with beta-adaptin in lymphoblast vesicles indicating that it may play a role in intracellular vesicle and/or protein transport mechanisms. No obvious nuclear localization signals have been detected in ATM. Neither an ectopically expressed N-terminal fragment of the protein nor a C-terminal fragment is capable of entering the nucleus.

Quality Tags

Ontology Terms



  1. Lamarche BJ, Orazio NI, Weitzman MD; ''The MRN complex in double-strand break repair and telomere maintenance.''; FEBS Lett, 2010 PubMed
  2. Ito CY, Adey N, Bautch VL, Baldwin AS Jr; ''Structure and evolution of the human IKBA gene.''; Genomics, 1995 PubMed
  3. Warmerdam DO, Kanaar R; ''Dealing with DNA damage: relationships between checkpoint and repair pathways.''; Mutat Res, 2010 PubMed
  4. Soulier J; ''Fanconi anemia.''; Hematology Am Soc Hematol Educ Program, 2011 PubMed
  5. Francis D; ''The G2/M transition in eukaryotes.''; SEB Exp Biol Ser, 2008 PubMed
  6. Troy CM, Shelanski ML; ''Caspase-2 redux.''; Cell Death Differ, 2003 PubMed
  7. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT; ''Apoptosis: molecular regulation of cell death.''; Eur J Biochem, 1996 PubMed
  8. Levav-Cohen Y, Goldberg Z, Zuckerman V, Grossman T, Haupt S, Haupt Y; ''C-Abl as a modulator of p53.''; Biochem Biophys Res Commun, 2005 PubMed
  9. Moldovan GL, D'Andrea AD; ''How the fanconi anemia pathway guards the genome.''; Annu Rev Genet, 2009 PubMed
  10. Shaul Y, Ben-Yehoyada M; ''Role of c-Abl in the DNA damage stress response.''; Cell Res, 2005 PubMed
  11. Goodarzi AA, Jeggo PA; ''The repair and signaling responses to DNA double-strand breaks.''; Adv Genet, 2013 PubMed
  12. Yang XH, Zou L; ''Checkpoint and coordinated cellular responses to DNA damage.''; Results Probl Cell Differ, 2006 PubMed
  13. Zhan Q; ''Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damage.''; Mutat Res, 2005 PubMed
  14. Kronja I, Orr-Weaver TL; ''Translational regulation of the cell cycle: when, where, how and why?''; Philos Trans R Soc Lond B Biol Sci, 2011 PubMed
  15. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T; ''The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.''; Sci Signal, 2010 PubMed
  16. Pei D, Zhang Y, Zheng J; ''Regulation of p53: a collaboration between Mdm2 and Mdmx.''; Oncotarget, 2012 PubMed
  17. Costanzo V; ''Brca2, Rad51 and Mre11: performing balancing acts on replication forks.''; DNA Repair (Amst), 2011 PubMed
  18. Medema RH, Macurek L; ''Checkpoint control and cancer.''; Oncogene, 2012 PubMed
  19. Pommier Y, Sordet O, Rao VA, Zhang H, Kohn KW; ''Targeting chk2 kinase: molecular interaction maps and therapeutic rationale.''; Curr Pharm Des, 2005 PubMed
  20. Dickey JS, Redon CE, Nakamura AJ, Baird BJ, Sedelnikova OA, Bonner WM; ''H2AX: functional roles and potential applications.''; Chromosoma, 2009 PubMed
  21. Maugeri-Sacca  M, Bartucci M, De Maria R; ''DNA damage repair pathways in cancer stem cells.''; Mol Cancer Ther, 2012 PubMed
  22. Tapia-Alveal C, Calonge TM, O'Connell MJ; ''Regulation of chk1.''; Cell Div, 2009 PubMed
  23. Marinoglou K; ''The role of the DNA damage response kinase ataxia telangiectasia mutated in neuroprotection.''; Yale J Biol Med, 2012 PubMed
  24. Pichierri P, Rosselli F; ''Fanconi anemia proteins and the s phase checkpoint.''; Cell Cycle, 2004 PubMed
  25. Sedukhina A, Fukuda T, Ohta T; ''[BRCA1 and DNA damage response].''; Seikagaku, 2012 PubMed
  26. Evan GI, d'Adda di Fagagna F; ''Cellular senescence: hot or what?''; Curr Opin Genet Dev, 2009 PubMed
  27. Aressy B, Ducommun B; ''Cell cycle control by the CDC25 phosphatases.''; Anticancer Agents Med Chem, 2008 PubMed
  28. Lenos K, Jochemsen AG; ''Functions of MDMX in the modulation of the p53-response.''; J Biomed Biotechnol, 2011 PubMed
  29. Chen W, Li Z, Bai L, Lin Y; ''NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target.''; Front Biosci, 2011 PubMed
  30. Oren M; ''Relationship of p53 to the control of apoptotic cell death.''; Semin Cancer Biol, 1994 PubMed
  31. Oluwagbemiga LA, Oluwole A, Kayode AA; ''Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review.''; Springerplus, 2012 PubMed
  32. Kastan MB, Canman CE, Leonard CJ; ''P53, cell cycle control and apoptosis: implications for cancer.''; Cancer Metastasis Rev, 1995 PubMed
  33. Wang Q, Maniati M, Jabado O, Pavlaki M, Troy CM, Greene LA, Stefanis L; ''RAIDD is required for apoptosis of PC12 cells and sympathetic neurons induced by trophic factor withdrawal.''; Cell Death Differ, 2006 PubMed
  34. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES; ''Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria.''; J Biol Chem, 2002 PubMed
  35. Nishina H, Wada T, Katada T; ''Physiological roles of SAPK/JNK signaling pathway.''; J Biochem, 2004 PubMed
  36. Enders GH; ''Expanded roles for Chk1 in genome maintenance.''; J Biol Chem, 2008 PubMed
  37. Hydbring P, Larsson LG; ''Cdk2: a key regulator of the senescence control function of Myc.''; Aging (Albany NY), 2010 PubMed
  38. Enoch T, Norbury C; ''Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM.''; Trends Biochem Sci, 1995 PubMed
  39. Gonfloni S, Maiani E, Di Bartolomeo C, Diederich M, Cesareni G; ''Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases?''; Int J Cell Biol, 2012 PubMed
  40. Hildesheim J, Fornace AJ Jr; ''Gadd45a: an elusive yet attractive candidate gene in pancreatic cancer.''; Clin Cancer Res, 2002 PubMed
  41. Gozdecka M, Breitwieser W; ''The roles of ATF2 (activating transcription factor 2) in tumorigenesis.''; Biochem Soc Trans, 2012 PubMed
  42. Hasselbach L, Haase S, Fischer D, Kolberg HC, Sturzbecher HW; ''Characterisation of the promoter region of the human DNA-repair gene Rad51.''; Eur J Gynaecol Oncol, 2005 PubMed
  43. Wu D, Cui F, Jernigan R, Wu Z; ''PIDD: database for Protein Inter-atomic Distance Distributions.''; Nucleic Acids Res, 2007 PubMed
  44. Zhang J, Zhang H, Li J, Rosenberg S, Zhang EC, Zhou X, Qin F, Farabaugh M; ''RIP1-mediated regulation of lymphocyte survival and death responses.''; Immunol Res, 2011 PubMed
  45. Rosemary Siafakas A, Richardson DR; ''Growth arrest and DNA damage-45 alpha (GADD45alpha).''; Int J Biochem Cell Biol, 2009 PubMed
  46. Nagathihalli NS, Nagaraju G; ''RAD51 as a potential biomarker and therapeutic target for pancreatic cancer.''; Biochim Biophys Acta, 2011 PubMed
  47. Filippini1 SE, Vega A; ''Breast cancer genes: beyond BRCA1 and BRCA2.''; Front Biosci, 2013 PubMed
  48. Hu W, Feng Z, Levine AJ; ''The Regulation of Multiple p53 Stress Responses is Mediated through MDM2.''; Genes Cancer, 2012 PubMed
  49. Fernandez-Capetillo O, Celeste A, Nussenzweig A; ''Focusing on foci: H2AX and the recruitment of DNA-damage response factors.''; Cell Cycle, 2003 PubMed
  50. Yasuda H, Kamijo M, Ohba Y; ''[The characterization of human cdc2 kinase and CDK2].''; Yakugaku Zasshi, 1993 PubMed
  51. Bay JO, Uhrhammer N, Stoppa-Lyonnet D, Hall J; ''[Role of the ATM gene in genetic predisposition to cancer].''; Bull Cancer, 2000 PubMed
  52. Stiewe T, Putzer BM; ''p73 in apoptosis.''; Apoptosis, 2001 PubMed
  53. Rotman G, Shiloh Y; ''ATM: from gene to function.''; Hum Mol Genet, 1998 PubMed
  54. Caestecker KW, Van de Walle GR; ''The role of BRCA1 in DNA double-strand repair: past and present.''; Exp Cell Res, 2013 PubMed
  55. Hershko A; ''Mechanisms and regulation of the degradation of cyclin B.''; Philos Trans R Soc Lond B Biol Sci, 1999 PubMed
  56. Verheij M, Ruiter GA, Zerp SF, van Blitterswijk WJ, Fuks Z, Haimovitz-Friedman A, Bartelink H; ''The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis.''; Radiother Oncol, 1998 PubMed
  57. Berube C, Boucher LM, Ma W, Wakeham A, Salmena L, Hakem R, Yeh WC, Mak TW, Benchimol S; ''Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD.''; Proc Natl Acad Sci U S A, 2005 PubMed
  58. Heideker J, Lis ET, Romesberg FE; ''Phosphatases, DNA damage checkpoints and checkpoint deactivation.''; Cell Cycle, 2007 PubMed
  59. Zhivotovsky B, Orrenius S; ''Caspase-2 function in response to DNA damage.''; Biochem Biophys Res Commun, 2005 PubMed
  60. Henning W, Sturzbecher HW; ''Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance.''; Toxicology, 2003 PubMed
  61. Liu VF, Boubnov NV, Weaver DT; ''Cell cycle checkpoints and repair of ionizing radiation damage.''; Stem Cells, 1995 PubMed
  62. Zhang XF, Tang WR, Luo Y; ''[Aging or tumor: the crosstalk between telomerase and p53].''; Yi Chuan, 2009 PubMed
  63. Miyamoto S; ''Nuclear initiated NF-kB signaling: NEMO and ATM take center stage.''; Cell Res, 2011 PubMed
  64. Shen T, Huang S; ''The role of Cdc25A in the regulation of cell proliferation and apoptosis.''; Anticancer Agents Med Chem, 2012 PubMed
  65. Coster G, Goldberg M; ''The cellular response to DNA damage: a focus on MDC1 and its interacting proteins.''; Nucleus, 2010 PubMed
  66. Castro E, Eeles R; ''The role of BRCA1 and BRCA2 in prostate cancer.''; Asian J Androl, 2012 PubMed
  67. Yuan J, Adamski R, Chen J; ''Focus on histone variant H2AX: to be or not to be.''; FEBS Lett, 2010 PubMed
  68. Smith J, Tho LM, Xu N, Gillespie DA; ''The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.''; Adv Cancer Res, 2010 PubMed
  69. Shaul Y; ''c-Abl: activation and nuclear targets.''; Cell Death Differ, 2000 PubMed
  70. Mladenov E, Iliakis G; ''Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways.''; Mutat Res, 2011 PubMed
  71. Draetta G; ''Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation.''; Trends Biochem Sci, 1990 PubMed
  72. Cornils H, Kohler RS, Hergovich A, Hemmings BA; ''Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression.''; Cell Cycle, 2011 PubMed
  73. Groth A, Lukas J, Nigg EA, Sillje HH, Wernstedt C, Bartek J, Hansen K; ''Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint.''; EMBO J, 2003 PubMed
  74. Lehman JA, Mayo LD; ''Integration of DNA damage and repair with murine double-minute 2 (mdm2) in tumorigenesis.''; Int J Mol Sci, 2012 PubMed
  75. Srivastava N, Gochhait S, de Boer P, Bamezai RN; ''Role of H2AX in DNA damage response and human cancers.''; Mutat Res, 2009 PubMed
  76. Barboule N, Lafon C, Chadebech P, Vidal S, Valette A; ''Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition.''; FEBS Lett, 1999 PubMed
  77. Gross A; ''BID as a double agent in cell life and death.''; Cell Cycle, 2006 PubMed
  78. Vakifahmetoglu-Norberg H, Zhivotovsky B; ''The unpredictable caspase-2: what can it do?''; Trends Cell Biol, 2010 PubMed
  79. Stracker TH, Petrini JH; ''The MRE11 complex: starting from the ends.''; Nat Rev Mol Cell Biol, 2011 PubMed
  80. Duan H, Dixit VM; ''RAIDD is a new 'death' adaptor molecule.''; Nature, 1997 PubMed
  81. Brooks CL, Gu W; ''Dynamics in the p53-Mdm2 ubiquitination pathway.''; Cell Cycle, 2004 PubMed
  82. Pines J; ''Cyclins and cyclin-dependent kinases: a biochemical view.''; Biochem J, 1995 PubMed
  83. Wade M, Li YC, Wahl GM; ''MDM2, MDMX and p53 in oncogenesis and cancer therapy.''; Nat Rev Cancer, 2013 PubMed
  84. Firsanov DV, Solovjeva LV, Svetlova MP; ''H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues.''; Clin Epigenetics, 2011 PubMed
  85. Marine JC, Dyer MA, Jochemsen AG; ''MDMX: from bench to bedside.''; J Cell Sci, 2007 PubMed
  86. Rotman G, Shiloh Y; ''Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?''; Bioessays, 1997 PubMed
  87. Williams RS, Williams JS, Tainer JA; ''Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template.''; Biochem Cell Biol, 2007 PubMed
  88. Castellino RC, De Bortoli M, Lin LL, Skapura DG, Rajan JA, Adesina AM, Perlaky L, Irwin MS, Kim JY; ''Overexpressed TP73 induces apoptosis in medulloblastoma.''; BMC Cancer, 2007 PubMed
  89. Shinohara A, Ogawa T; ''Rad51/RecA protein families and the associated proteins in eukaryotes.''; Mutat Res, 1999 PubMed
  90. Merry C, Fu K, Wang J, Yeh IJ, Zhang Y; ''Targeting the checkpoint kinase Chk1 in cancer therapy.''; Cell Cycle, 2010 PubMed
  91. Greer Card DA, Sierant ML, Davey S; ''Rad9A is required for G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibition.''; J Biol Chem, 2010 PubMed
  92. Krumschnabel G, Manzl C, Villunger A; ''Caspase-2: killer, savior and safeguard--emerging versatile roles for an ill-defined caspase.''; Oncogene, 2009 PubMed
  93. Porter LA, Donoghue DJ; ''Cyclin B1 and CDK1: nuclear localization and upstream regulators.''; Prog Cell Cycle Res, 2003 PubMed
  94. Ribe EM, Jean YY, Goldstein RL, Manzl C, Stefanis L, Villunger A, Troy CM; ''Neuronal caspase 2 activity and function requires RAIDD, but not PIDD.''; Biochem J, 2012 PubMed
  95. Leonard CJ, Canman CE, Kastan MB; ''The role of p53 in cell-cycle control and apoptosis: implications for cancer.''; Important Adv Oncol, 1995 PubMed
  96. Ma Z, Lin M, Li K, Fu Y, Liu X, Yang D, Zhao Y, Zheng J, Sun B; ''Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells.''; Int J Clin Exp Pathol, 2013 PubMed
  97. Ando K, Kernan JL, Liu PH, Sanda T, Logette E, Tschopp J, Look AT, Wang J, Bouchier-Hayes L, Sidi S; ''PIDD death-domain phosphorylation by ATM controls prodeath versus prosurvival PIDDosome signaling.''; Mol Cell, 2012 PubMed
  98. Finn K, Lowndes NF, Grenon M; ''Eukaryotic DNA damage checkpoint activation in response to double-strand breaks.''; Cell Mol Life Sci, 2012 PubMed
  99. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA; ''p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.''; Oncogene, 1999 PubMed
  100. Meuth M; ''Chk1 suppressed cell death.''; Cell Div, 2010 PubMed
  101. Reinhardt HC, Yaffe MB; ''Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.''; Curr Opin Cell Biol, 2009 PubMed
  102. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P; ''RIP1, a kinase on the crossroads of a cell's decision to live or die.''; Cell Death Differ, 2007 PubMed
  103. Mirzayans R, Andrais B, Scott A, Murray D; ''New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy.''; J Biomed Biotechnol, 2012 PubMed
  104. Shadfan M, Lopez-Pajares V, Yuan ZM; ''MDM2 and MDMX: Alone and together in regulation of p53.''; Transl Cancer Res, 2012 PubMed
  105. Wu ZH, Mabb A, Miyamoto S; ''PIDD: a switch hitter.''; Cell, 2005 PubMed
  106. Arthur LM, Heber-Katz E; ''The role of p21 in regulating mammalian regeneration.''; Stem Cell Res Ther, 2011 PubMed
  107. Lee JM, Bernstein A; ''Apoptosis, cancer and the p53 tumour suppressor gene.''; Cancer Metastasis Rev, 1995 PubMed
  108. Janssens S, Tinel A, Lippens S, Tschopp J; ''PIDD mediates NF-kappaB activation in response to DNA damage.''; Cell, 2005 PubMed
  109. Blandino G, Dobbelstein M; ''p73 and p63: why do we still need them?''; Cell Cycle, 2004 PubMed
  110. Vispe S, Defais M; ''Mammalian Rad51 protein: a RecA homologue with pleiotropic functions.''; Biochimie, 1997 PubMed
  111. Perona R, Moncho-Amor V, Machado-Pinilla R, Belda-Iniesta C, Sanchez Perez I; ''Role of CHK2 in cancer development.''; Clin Transl Oncol, 2008 PubMed
  112. McCool KW, Miyamoto S; ''DNA damage-dependent NF-kB activation: NEMO turns nuclear signaling inside out.''; Immunol Rev, 2012 PubMed
  113. Nowsheen S, Yang ES; ''The intersection between DNA damage response and cell death pathways.''; Exp Oncol, 2012 PubMed
  114. Li H, Bergeron L, Cryns V, Pasternack MS, Zhu H, Shi L, Greenberg A, Yuan J; ''Activation of caspase-2 in apoptosis.''; J Biol Chem, 1997 PubMed
  115. Enserink JM, Kolodner RD; ''An overview of Cdk1-controlled targets and processes.''; Cell Div, 2010 PubMed
  116. Bouchier-Hayes L; ''The role of caspase-2 in stress-induced apoptosis.''; J Cell Mol Med, 2010 PubMed
  117. Gerlitz G; ''HMGNs, DNA repair and cancer.''; Biochim Biophys Acta, 2010 PubMed
  118. Gilmore TD, Wolenski FS; ''NF-kB: where did it come from and why?''; Immunol Rev, 2012 PubMed
  119. Marignol L, Coffey M, Hollywood D, Lawler M; ''Radiation to control transgene expression in tumors.''; Cancer Biol Ther, 2007 PubMed
  120. Yasuda H; ''[Regulation of cell cycle by cdc2 kinase in mammalian cells].''; Seikagaku, 1992 PubMed
  121. Biderman L, Manley JL, Prives C; ''Mdm2 and MdmX as Regulators of Gene Expression.''; Genes Cancer, 2012 PubMed
  122. Maas AM, Bretz AC, Mack E, Stiewe T; ''Targeting p73 in cancer.''; Cancer Lett, 2013 PubMed
  123. Savitsky K, Platzer M, Uziel T, Gilad S, Sartiel A, Rosenthal A, Elroy-Stein O, Shiloh Y, Rotman G; ''Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression.''; Nucleic Acids Res, 1997 PubMed
  124. Bhoumik A, Lopez-Bergami P, Ronai Z; ''ATF2 on the double - activating transcription factor and DNA damage response protein.''; Pigment Cell Res, 2007 PubMed
  125. Egloff AM, Vella LA, Finn OJ; ''Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer.''; Cancer Res, 2006 PubMed
  126. Rufini A, Tucci P, Celardo I, Melino G; ''Senescence and aging: the critical roles of p53.''; Oncogene, 2013 PubMed
  127. Moroy T, Geisen C; ''Cyclin E.''; Int J Biochem Cell Biol, 2004 PubMed
  128. Taylor AK, Klisak I, Mohandas T, Sparkes RS, Li C, Gaynor R, Lusis AJ; ''Assignment of the human gene for CREB1 to chromosome 2q32.3-q34.''; Genomics, 1990 PubMed
  129. Krumschnabel G, Sohm B, Bock F, Manzl C, Villunger A; ''The enigma of caspase-2: the laymen's view.''; Cell Death Differ, 2009 PubMed
  130. Reinhardt HC, Schumacher B; ''The p53 network: cellular and systemic DNA damage responses in aging and cancer.''; Trends Genet, 2012 PubMed
  131. Williams GJ, Lees-Miller SP, Tainer JA; ''Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks.''; DNA Repair (Amst), 2010 PubMed
  132. Tanaka T; ''[Mechanisms of cellular senescence by tumor suppressor p53].''; Nihon Rinsho, 2011 PubMed
  133. Muller PA, Vousden KH; ''p53 mutations in cancer.''; Nat Cell Biol, 2013 PubMed
  134. Matsushita N, Kitao H, Ishiai M, Takata M; ''[Fanconi anemia and DNA-damage response network].''; Tanpakushitsu Kakusan Koso, 2009 PubMed
  135. Barnes DM, Camplejohn RS; ''P53, apoptosis, and breast cancer.''; J Mammary Gland Biol Neoplasia, 1996 PubMed
  136. Ghosh G, Wang VY, Huang DB, Fusco A; ''NF-kB regulation: lessons from structures.''; Immunol Rev, 2012 PubMed
  137. Esposti MD; ''The roles of Bid.''; Apoptosis, 2002 PubMed
  138. Jungmichel S, Stucki M; ''MDC1: The art of keeping things in focus.''; Chromosoma, 2010 PubMed
  139. Lam MH, Rosen JM; ''Chk1 versus Cdc25: chking one's levels of cellular proliferation.''; Cell Cycle, 2004 PubMed
  140. Doree M, Hunt T; ''From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner?''; J Cell Sci, 2002 PubMed
  141. Papadopoulo D, Moustacchi E; ''[Fanconi anemia: genes and function(s) revisited].''; Med Sci (Paris), 2005 PubMed
  142. Sutherland RL, Musgrove EA; ''Cyclins and breast cancer.''; J Mammary Gland Biol Neoplasia, 2004 PubMed
  143. Czornak K, Chughtai S, Chrzanowska KH; ''Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair.''; J Appl Genet, 2008 PubMed
  144. Tchou WW, Rom WN, Tchou-Wong KM; ''Novel form of p21(WAF1/CIP1/SDI1) protein in phorbol ester-induced G2/M arrest.''; J Biol Chem, 1996 PubMed
  145. Lavin MF; ''ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks.''; Oncogene, 2007 PubMed
  146. Qian Y, Chen X; ''Senescence regulation by the p53 protein family.''; Methods Mol Biol, 2013 PubMed
  147. Manfredi JJ; ''The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.''; Genes Dev, 2010 PubMed
  148. Niida H, Nakanishi M; ''DNA damage checkpoints in mammals.''; Mutagenesis, 2006 PubMed
  149. Kuroda S, Urata Y, Fujiwara T; ''Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization.''; Acta Med Okayama, 2012 PubMed
  150. Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C, Reed SI; ''Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.''; Mol Cell Biol, 1998 PubMed
  151. Shiloh Y, Kastan MB; ''ATM: genome stability, neuronal development, and cancer cross paths.''; Adv Cancer Res, 2001 PubMed
  152. Tsai LH, Harlow E, Meyerson M; ''Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.''; Nature, 1991 PubMed
  153. Klein HL; ''The consequences of Rad51 overexpression for normal and tumor cells.''; DNA Repair (Amst), 2008 PubMed
  154. Shahbazi J, Lock R, Liu T; ''Tumor Protein 53-Induced Nuclear Protein 1 Enhances p53 Function and Represses Tumorigenesis.''; Front Genet, 2013 PubMed
  155. Shalom S, Don J; ''Tlk, a novel evolutionarily conserved murine serine threonine kinase, encodes multiple testis transcripts.''; Mol Reprod Dev, 1999 PubMed
  156. Nevanlinna H, Bartek J; ''The CHEK2 gene and inherited breast cancer susceptibility.''; Oncogene, 2006 PubMed
  157. Thacker J; ''The RAD51 gene family, genetic instability and cancer.''; Cancer Lett, 2005 PubMed
  158. Sahin E, DePinho RA; ''Axis of ageing: telomeres, p53 and mitochondria.''; Nat Rev Mol Cell Biol, 2012 PubMed
  159. Bisso A, Collavin L, Del Sal G; ''p73 as a pharmaceutical target for cancer therapy.''; Curr Pharm Des, 2011 PubMed
  160. Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG; ''ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.''; Cell Cycle, 2005 PubMed
  161. Gotz C, Montenarh M; ''p53: DNA damage, DNA repair, and apoptosis.''; Rev Physiol Biochem Pharmacol, 1996 PubMed
  162. Liebermann DA, Tront JS, Sha X, Mukherjee K, Mohamed-Hadley A, Hoffman B; ''Gadd45 stress sensors in malignancy and leukemia.''; Crit Rev Oncog, 2011 PubMed
  163. Stiewe T, Putzer BM; ''Role of p73 in malignancy: tumor suppressor or oncogene?''; Cell Death Differ, 2002 PubMed
  164. Iijima K, Ohara M, Seki R, Tauchi H; ''Dancing on damaged chromatin: functions of ATM and the RAD50/MRE11/NBS1 complex in cellular responses to DNA damage.''; J Radiat Res, 2008 PubMed
  165. Thomasova D, Mulay SR, Bruns H, Anders HJ; ''p53-independent roles of MDM2 in NF-kB signaling: implications for cancer therapy, wound healing, and autoimmune diseases.''; Neoplasia, 2012 PubMed
  166. Bouchier-Hayes L, Green DR; ''Caspase-2: the orphan caspase.''; Cell Death Differ, 2012 PubMed
  167. Sunavala-Dossabhoy G, De Benedetti A; ''Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair.''; DNA Repair (Amst), 2009 PubMed
  168. Pinder JB, Attwood KM, Dellaire G; ''Reading, writing, and repair: the role of ubiquitin and the ubiquitin-like proteins in DNA damage signaling and repair.''; Front Genet, 2013 PubMed
  169. Vasileva A, Hopkins KM, Wang X, Weissbach MM, Friedman RA, Wolgemuth DJ, Lieberman HB; ''The DNA damage checkpoint protein RAD9A is essential for male meiosis in the mouse.''; J Cell Sci, 2013 PubMed
  170. Wolf F, Sigl R, Geley S; '''... The end of the beginning': cdk1 thresholds and exit from mitosis.''; Cell Cycle, 2007 PubMed
  171. Yang C, Hornicek FJ, Wood KB, Schwab JH, Mankin H, Duan Z; ''RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.''; Cancer Chemother Pharmacol, 2009 PubMed
  172. Canman CE, Chen CY, Lee MH, Kastan MB; ''DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis.''; Cold Spring Harb Symp Quant Biol, 1994 PubMed
  173. Hollander MC, Fornace AJ Jr; ''Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a.''; Oncogene, 2002 PubMed
  174. Kawabata M, Kawabata T, Nishibori M; ''Role of recA/RAD51 family proteins in mammals.''; Acta Med Okayama, 2005 PubMed
  175. McCoy F, Eckard L, Nutt LK; ''Janus-faced PIDD: a sensor for DNA damage-induced cell death or survival?''; Mol Cell, 2012 PubMed
  176. Chiarugi V, Magnelli L, Cinelli M, Basi G; ''Apoptosis and the cell cycle.''; Cell Mol Biol Res, 1994 PubMed
  177. Johnson N, Cai D, Kennedy RD, Pathania S, Arora M, Li YC, D'Andrea AD, Parvin JD, Shapiro GI; ''Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.''; Mol Cell, 2009 PubMed
  178. Tanaka T, Huang X, Halicka HD, Zhao H, Traganos F, Albino AP, Dai W, Darzynkiewicz Z; ''Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.''; Cytometry A, 2007 PubMed
  179. Jang TH, Park HH; ''Purification, crystallization and preliminary x-ray crystallographic studies of RAIDD Death-Domain (DD).''; Int J Mol Sci, 2009 PubMed
  180. Jacquemont C, Taniguchi T; ''The Fanconi anemia pathway and ubiquitin.''; BMC Biochem, 2007 PubMed
  181. ''[Caspase-2: what do we know today?].''; Mol Biol (Mosk), 2013 PubMed
  182. McCubrey J, Demidenko Z; ''Recent discoveries in the cycling, growing and aging of the p53 field.''; Aging (Albany NY), 2012 PubMed
  183. Hinchcliffe EH, Sluder G; ''Two for two: Cdk2 and its role in centrosome doubling.''; Oncogene, 2002 PubMed
  184. Hu X, Moscinski LC; ''Cdc2: a monopotent or pluripotent CDK?''; Cell Prolif, 2011 PubMed
  185. Thompson LH; ''Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography.''; Mutat Res, 2012 PubMed
  186. Bhoumik A, Ronai Z; ''ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities.''; Cell Cycle, 2008 PubMed
  187. Zhang J; ''The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy.''; Cell Biosci, 2013 PubMed
  188. Fernandez-Vidal A, Mazars A, Manenti S; ''CDC25A: a rebel within the CDC25 phosphatases family?''; Anticancer Agents Med Chem, 2008 PubMed
  189. Rosen EM; ''BRCA1 in the DNA damage response and at telomeres.''; Front Genet, 2013 PubMed
  190. Jeggo PA, Geuting V, Lobrich M; ''The role of homologous recombination in radiation-induced double-strand break repair.''; Radiother Oncol, 2011 PubMed
  191. Kumar S; ''Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?''; Nat Rev Cancer, 2009 PubMed
  192. Neely KE, Piwnica-Worms H; ''Cdc25A regulation: to destroy or not to destroy--is that the only question?''; Cell Cycle, 2003 PubMed
  193. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT; ''Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.''; Oncogene, 1999 PubMed
  194. Hinds PW; ''Cdk2 dethroned as master of S phase entry.''; Cancer Cell, 2003 PubMed
  195. Paull TT; ''Making the best of the loose ends: Mre11/Rad50 complexes and Sae2 promote DNA double-strand break resection.''; DNA Repair (Amst), 2010 PubMed
  196. Karlsson-Rosenthal C, Millar JB; ''Cdc25: mechanisms of checkpoint inhibition and recovery.''; Trends Cell Biol, 2006 PubMed
  197. Kaldis P, Aleem E; ''Cell cycle sibling rivalry: Cdc2 vs. Cdk2.''; Cell Cycle, 2005 PubMed
  198. Heintz N; ''Ataxia telangiectasia: cell signaling, cell death and the cell cycle.''; Curr Opin Neurol, 1996 PubMed
  199. Ito M; ''Factors controlling cyclin B expression.''; Plant Mol Biol, 2000 PubMed
  200. Chen Y, Poon RY; ''The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.''; Front Biosci, 2008 PubMed
  201. Salaun P, Rannou Y, Prigent C; ''Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards.''; Adv Exp Med Biol, 2008 PubMed
  202. Lindqvist A, Rodriguez-Bravo V, Medema RH; ''The decision to enter mitosis: feedback and redundancy in the mitotic entry network.''; J Cell Biol, 2009 PubMed
  203. Smits VA, Warmerdam DO, Martin Y, Freire R; ''Mechanisms of ATR-mediated checkpoint signalling.''; Front Biosci, 2010 PubMed
  204. Marine JC, Jochemsen AG; ''Mdmx and Mdm2: brothers in arms?''; Cell Cycle, 2004 PubMed
  205. Zgheib O, Huyen Y, DiTullio RA Jr, Snyder A, Venere M, Stavridi ES, Halazonetis TD; ''ATM signaling and 53BP1.''; Radiother Oncol, 2005 PubMed
  206. Bock FJ, Krumschnabel G, Manzl C, Peintner L, Tanzer MC, Hermann-Kleiter N, Baier G, Llacuna L, Yelamos J, Villunger A; ''Loss of PIDD limits NF-kB activation and cytokine production but not cell survival or transformation after DNA damage.''; Cell Death Differ, 2013 PubMed
  207. Richardson C; ''RAD51, genomic stability, and tumorigenesis.''; Cancer Lett, 2005 PubMed
View all...


View all...
90247view 14:13, 26 October 2016AmanzoModification of some titles
90241view 10:50, 26 October 2016AmanzoModification on titles of some paths
90240view 10:29, 26 October 2016AmanzoPeriodical save, work in progress
84490view 16:16, 25 February 2016KhanspersQuick edit to datanode annotation or property
81224view 16:13, 5 August 2015AlexanderPicoremoving final IE-incompatible character
81223view 15:54, 5 August 2015AlexanderPicoremoving more IE-incompatible character
81218view 12:15, 5 August 2015AlexanderPicoremoving IE-incompatible character
79964view 07:04, 28 April 2015ZariChanged Id UniProt to Entrez gene for CDC2
78531view 03:30, 7 January 2015MaintBotadded missing graphIds
76317view 23:53, 1 July 2014MkutmonFixed datasource of S Phase Arrest pathway datanode
72241view 11:46, 29 October 2013Khanspersadded one more WP node
72240view 11:45, 29 October 2013Khansperschanged pathway node xrefs from GO to WP
71697view 12:44, 17 October 2013MaintBotUpdated data sources
70531view 09:44, 9 August 2013AmanzoWork in progress
70530view 09:42, 9 August 2013AmanzoPeriodical save, work in progress
70529view 09:11, 9 August 2013AmanzoPeriodical save, work in progress
70528view 09:01, 9 August 2013AmanzoPeriodical save, work in progress
70527view 08:50, 9 August 2013AmanzoPeriodical save, work in progress
70458view 15:04, 3 August 2013AmanzoPeriodical save, work in progress
70457view 14:54, 3 August 2013AmanzoPeriodical save, work in progress
70446view 12:05, 1 August 2013AmanzoPeriodical save, work in progress
70445view 11:55, 1 August 2013AmanzoPeriodical save, work in progress
70444view 11:44, 1 August 2013AmanzoPeriodical save, work in progress
70085view 08:44, 12 July 2013AmanzoModified description
70084view 08:33, 12 July 2013Amanzowork in progress
70083view 08:31, 12 July 2013AmanzoIR figure fixed
70082view 08:27, 12 July 2013AmanzoPeriodical save, work in progress
70081view 08:13, 12 July 2013AmanzoPeriodical save, work in progress
70072view 02:01, 12 July 2013Mkutmonreplaced interaction lines in radiation figure with graphical lines
70004view 16:12, 11 July 2013AmanzoModified description
70003view 16:11, 11 July 2013AmanzoModified description
70002view 16:08, 11 July 2013AmanzoWork in progress
70000view 15:57, 11 July 2013AmanzoPeriodical save, work in progress
69999view 15:47, 11 July 2013AmanzoPeriodical save, work in progress
69998view 15:36, 11 July 2013AmanzoPeriodical save, work in progress
69706view 15:54, 9 July 2013AmanzoReferences added
69705view 15:49, 9 July 2013AmanzoPeriodical save, work in progress
69704view 15:39, 9 July 2013AmanzoPeriodical save, work in progress
69703view 15:35, 9 July 2013Amanzowork in progress
69702view 15:10, 9 July 2013AmanzoPeriodical save, work in progress
69701view 14:59, 9 July 2013AmanzoPeriodical save, work in progress
69698view 12:10, 9 July 2013AmanzoPeriodical save, work in progress
69697view 12:00, 9 July 2013AmanzoPeriodical save, work in progress
69696view 11:36, 9 July 2013AmanzoPeriodical save, work in progress
69695view 11:15, 9 July 2013AmanzoPeriodical save, work in progress
69694view 11:05, 9 July 2013AmanzoPeriodical save, work in progress
69693view 10:45, 9 July 2013AmanzoPeriodical save, work in progress
69692view 10:24, 9 July 2013AmanzoPeriodical save, work in progress
69691view 10:04, 9 July 2013AmanzoPeriodical save, work in progress
69690view 09:55, 9 July 2013AmanzoWork in progress

External references


View all...
NameTypeDatabase referenceComment
AP3B2ProteinQ13367 (Uniprot-TrEMBL)
ATF2GeneProductENSG00000115966 (Ensembl)
ATMGeneProductENSG00000149311 (Ensembl)
ApoptosisPathwayWP254 (WikiPathways)
BIDProteinP55957 (Uniprot-TrEMBL)
BRCA1ProteinP38398 (Uniprot-TrEMBL)
CCNE1GeneProductENSG00000105173 (Ensembl)
CDC25AGeneProductENSG00000164045 (Ensembl)
CDC25CGeneProductENSG00000158402 (Ensembl)
CDC2GeneProduct983 (Entrez Gene)
CDK1GeneProductENSG00000170312 (Ensembl)
CDK2ProteinP24941 (Uniprot-TrEMBL)
CREB1GeneProduct1385 (Entrez Gene)
Caspase 2GeneProductP42575 (Uniprot-TrEMBL)
Cell Cycle Checkpoint ActivationPathwayWP1775 (WikiPathways)
Cell DeathPathwayWP254 (WikiPathways)
Chk1ProteinO14757 (Uniprot-TrEMBL)
Chk2ProteinO96017 (Uniprot-TrEMBL)
Cyclin BGeneProduct891 (Entrez Gene)
DNA DAMAGEPathwayWP707 (WikiPathways)
DNA RepairPathwayWP707 (WikiPathways)
FANCD2ProteinQ9BXW9 (Uniprot-TrEMBL)
G1/S Checkpoint Arrest PathwayWP45 (WikiPathways)
G2/M Checkpoint ArrestPathwayWP1859 (WikiPathways)
G2/M TransitionPathwayWP1859 (WikiPathways)
GADD45AGeneProduct1647 (Entrez Gene)
H2AXProteinP16104 (Uniprot-TrEMBL)
IKBAProteinP25963 (Uniprot-TrEMBL)
MDC1ProteinQ14676 (Uniprot-TrEMBL)
MDM2ProteinQ00987 (Uniprot-TrEMBL)
MDMX (MDM4)GeneProductO15151 (Uniprot-TrEMBL)
MRE11ProteinP49959 (Uniprot-TrEMBL)
NBS1ProteinO60934 (Uniprot-TrEMBL)
NEMOProteinQ9Y6K9 (Uniprot-TrEMBL)
NF kappa B PathwayPathwayko04064 (KEGG Pathway)
PIDDGeneProductENSG00000177595 (Ensembl)
RAD50ProteinQ92878 (Uniprot-TrEMBL)
RAD51GeneProductENSG00000051180 (Ensembl)
RAD9AGeneProductENSG00000172613 (Ensembl)
RAIDDGeneProductP78560 (Uniprot-TrEMBL)
RIP1GeneProductQ13546 (Uniprot-TrEMBL)
RecombinationPathwayWP438 (WikiPathways)
S Phase ProgressionPathwayWP45 (WikiPathways)
S Phase ArrestPathwayWP45 (WikiPathways)
S Phase ProgressionPathwayWP45 (WikiPathways)
SAPK (MAPK9)GeneProductENSG00000050748 (Ensembl)
SMC1AProteinQ14683 (Uniprot-TrEMBL)
SenescencePathwayWP615 (WikiPathways)
TLK1ProteinQ9UKI8 (Uniprot-TrEMBL)
TP53BP1GeneProductENSG00000067369 (Ensembl)
TP53GeneProductENSG00000141510 (Ensembl)
TP73GeneProductENSG00000078900 (Ensembl)
c-AblGeneProductENSG00000097007 (Ensembl)
c-JunGeneProductENSG00000177606 (Ensembl)
p21GeneProductENSG00000124762 (Ensembl)

Annotated Interactions

<cite>No annotated interactions</cite>